ENZY Enzymotec Ltd. - Ordinary Shares (delisted)

Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, announced today that Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer, will present at the Jefferies 2014 Global Healthcare Conference on Thursday, June 5, 2014 at 11:00 a.m. ET in New York, NY.

The audio portion of Enzymotec's presentation will be webcast live, and a replay will be available on the Investors section of the Company's website at www.enzymotec.com.

About Enzymotec Ltd.

Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies.

CONTACT: ICR
         Katie Turner
         646-277-1228
         Katie.Turner@icrinc.com
         
         John Mills
         310-954-1105
         John.Mills@icrinc.com